You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Mallinckrodt
Dow
Baxter
Moodys

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011909


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 011909 describes NARDIL, which is a drug marketed by Parke Davis and is included in one NDA. It is available from two suppliers. Additional details are available on the NARDIL profile page.

The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
Summary for 011909
Tradename:NARDIL
Applicant:Parke Davis
Ingredient:phenelzine sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 011909
Mechanism of ActionMonoamine Oxidase Inhibitors
Medical Subject Heading (MeSH) Categories for 011909
Suppliers and Packaging for NDA: 011909
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NARDIL phenelzine sulfate TABLET;ORAL 011909 NDA Parke-Davis Div of Pfizer Inc 0071-0350 0071-0350-60 60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60)
NARDIL phenelzine sulfate TABLET;ORAL 011909 NDA AUTHORIZED GENERIC Greenstone LLC 59762-0119 59762-0119-1 60 TABLET, FILM COATED in 1 BOTTLE (59762-0119-1)

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Colorcon
Merck
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.